ResMed Inc. (RMD.AX)
Makes devices and software that help doctors diagnose and treat sleep apnea and respiratory problems.
29.99+0.04%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-30.1%
The outlook
ResMed (RMD.AX) trades at $29.99 with analyst consensus tilted toward Buy, and the average price target sits roughly 34% above current levels. The stock sits near its 52-week low end of its range, though price momentum relative to moving averages is mixed. A trailing P/E of 20.3 reflects moderate valuation against the backdrop of generally positive analyst sentiment.
What’s behind the score
Analyst consensusBuy — 1.5 avg of 13 analysts
Price trendMixed vs its moving averages
52-week range23% of the way from its 52-week low to high
Price targetAvg target +34% vs current price
Analyst price target
~12-month · 13 analysts40.27average target+34.3% vs now
Now 29.99
Low 33.99High 47.06
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$43.50B
52-wk high
45.25
52-wk low
25.50
50-day avg
28.40
200-day avg
33.67
Trailing P/E
20.3